Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice.
about
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humansCharacterization of the heat shock response in Brucella abortus and isolation of the genes encoding the GroE heat shock proteins.Impaired control of Brucella melitensis infection in Rag1-deficient miceExpression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometryProtection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitroYersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.Brucella melitensis invades murine erythrocytes during infection.Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosisPathogenesis and immunobiology of brucellosis: review of Brucella-host interactionsProtective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccinesB cells and antibodies in the defense against Mycobacterium tuberculosis infectionCrucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosisDeletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models.Novel Solutions for Vaccines and Diagnostics To Combat Brucellosis.Alternative strategies for vaccination to brucellosis.Protective role of specific murine antibodies in inhibiting systemic proliferation of virulent strain 544 in mice and guinea pig
P2860
Q24545524-30BF1EA1-BB4B-48B4-A057-3A933E28E371Q31162481-28672796-3501-4EAC-969A-0FA05CB5DF77Q33600101-C77FF0F3-0793-4302-9C10-12181D5D1CDAQ33752010-552EC404-439F-4D69-805D-B995A2F96385Q33756359-630BD31C-4ABE-476D-AE0E-76FC47B7A108Q33999640-6A59C00B-9D03-4B6B-8CD2-6A753AFAB0E2Q34002465-A8B307E9-5EF7-48FC-B8A1-8B570D4A4C08Q34003056-31978843-56E7-4F0C-9F56-71AC2DA13BEDQ34120666-470110AE-C7CC-4B93-9D60-00C51546AC30Q34298491-96E0092F-F0EB-4A03-A7C8-EB59966093E1Q35380623-5D95EFCA-2956-44CB-93C1-335999637EF3Q35432482-340D2402-683E-4F32-AC38-71DE0E149A3EQ35503256-85DEEB56-E53D-4806-8132-2FD164376496Q35669016-5817EE62-D69F-4E70-8F6B-854EF20F014CQ35773419-DBE0AC7C-CFEB-4F67-B09D-50BEE67D7A92Q36238031-EC31306A-8391-4D5C-B2D3-31E78D656EF1Q36396770-99041BEC-2006-46E4-8FAF-D718699E6D9DQ36948267-11659388-2A21-4A26-88BE-83405B8DAFF6Q37131961-0BA251AA-B847-496C-9723-546185683182Q39822825-263894D2-9DF2-4D44-AFA6-3CA3AB60A418Q39826917-05017C9B-59CC-4DBC-8961-409AE1698407Q40261059-FB56A6AA-561B-45B1-BC16-4C6CD8DDC471Q49486807-61C84124-8185-46EC-B4F4-284FF2CEF16EQ57095950-F8EDCDF6-EA65-45D4-AC13-A15CCB46D2AF
P2860
Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Capacity of passively administ ...... lla abortus infection in mice.
@en
Capacity of passively administ ...... lla abortus infection in mice.
@nl
type
label
Capacity of passively administ ...... lla abortus infection in mice.
@en
Capacity of passively administ ...... lla abortus infection in mice.
@nl
prefLabel
Capacity of passively administ ...... lla abortus infection in mice.
@en
Capacity of passively administ ...... lla abortus infection in mice.
@nl
P2093
P2860
P1476
Capacity of passively administ ...... ella abortus infection in mice
@en
P2093
Douglas JT
Santisteban CG
P2860
P304
P407
P577
1989-11-01T00:00:00Z